ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹106 Cr | ₹97 Cr | ₹87 Cr | ₹121 Cr | ₹115 Cr |
What is the latest Contingent Liabilities ratio of ABBOTT INDIA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹106 Cr |
| Mar2024 | ₹97 Cr |
| Mar2023 | ₹87 Cr |
| Mar2022 | ₹121 Cr |
| Mar2021 | ₹115 Cr |
How is Contingent Liabilities of ABBOTT INDIA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹106 Cr | 10.00 | |
| Mar2024 | ₹97 Cr | 10.44 | |
| Mar2023 | ₹87 Cr | -28.00 | |
| Mar2022 | ₹121 Cr | 5.32 | |
| Mar2021 | ₹115 Cr | - | |
Compare Contingent Liabilities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹59,388.8 Cr | 2.3% | 8% | -19.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | 2.3% |
8% |
-19.4% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses